P757: RESULTS OF A PHASE 1 STUDY OF AZACITIDINE COMBINED WITH VENETOCLAX FOR TREATMENT-NAIVE AND RELAPSED HIGH-RISK MYELODYSPLASTIC SYNDROME AND CHRONIC MYELOMONOCYTIC LEUKEMIA. (23rd June 2022) - Bazinet, A.; Jabbour, E.; Kantarjian, H.; Chien, K.; DiNardo, C.; Ohanian, M.; Daver, N.; Kanagal-Shamanna, R.; Kadia, T.; Takahashi, K.; Masarova, L.; Short, N.; et al.